fr

CCRM

Commercializing Living Therapies with CCRM

Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.

N'hésitez pas à visiter le site du podcast et à soutenir son créateur : www.ccrm.ca

Auteur

CCRM

Catégorie

Science

Site du podcast

www.ccrm.ca

Dernier épisode

15 oct. 2026

Où écouter ?

Les podcasts dans l'appli Replaio Radio Bientôt disponible

Les podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts

Télécharger sur Google Play Installe-la gratuitement Android 10 M+ de téléchargements · note de 4,7+ iOS bientôt

Épisodes

Moving from A to B 14.02.2022

Manufacturing and supply chain issues in cell and gene therapies.    Featuring:  Dr. Anthony Davies, Founder and CEO, Dark Horse Consulting  Rob Jones, Vice President, Global Bioservices, Cryoport Systems   It’s no secret that supply chain and manufacturing are crucial to the cell and gene therapy industry, but now the whole world seems to be paying attention. This sudden interest has made Anthony...

Chaperoning innovation through the valley of death 14.01.2022

The business of regenerative medicine and investment.   Featuring:  Dr. Cynthia Lavoie, President and Chief Investment Officer, CCRM Enterprises  Geoff MacKay, President and CEO, AVROBIO  Dr. Lavoie and Mr. MacKay share what brought them to regenerative medicine in the first place, why investors are bullish about the field, and which trends they have an eye on as they are looking to the future. Jo...

The importance of educating the public about cell and gene therapies 14.12.2021

How can the regenerative medicine community create broader societal awareness?  Featuring:  Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation Dr. Phil Vanek, Chief Technology Officer, Gamma Biosciences Drs. Rossant and Vanek discuss public awareness of cell and gene therapies, the importance of improving it, and how confusing and misleading claims made about unapproved stem...

Écoute le podcast Commercializing Living Therapies with CCRM sur Replaio

La radio et les podcasts dans une seule appli - gratuite, sans inscription. Installe-la dès aujourd'hui et ne rate pas le lancement

Télécharger sur Google Play

Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics